Shah Capital intends to vote against Novavax's board nominees, executive compensation

Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive ​compensation package at Novavax's upcoming annual meeting, renewing pressure for ‌changes at the vaccine maker.